Eric Lefkofsky’s Fixation On Cancer

Cancer, Technology
Eric Lefkofsky is a man known for many of his contributions to causes such as civic causes, human rights, education and medical discoveries. He mainly puts his focus on cancer, him being a Chief Executive Officer and co-founder of Tempus, a technology company that created a cancer-battling operating system. The system gives data that is both attainable and useful for the benefit of patients. This data derived from the treatment of previous patients. He is a firm believer of reducing mortality rates and improving management of diseases and patient treatment. He says making advances in molecular sequences, artificial intelligence and machine learning are what arm us in battling cancer, which has been a big challenge since time in memorial. Together with their vast range of experts at T...

Cancer Treatment Center of America Fighting Prostate Cancer

Cancer, Medical
Prostate cancer affects many men in their lifetime. Different organizations have therefore joined hands to increase awareness about the scorching disease. The Cancer Treatment of America, the LabCorp, and the National Football League Alumni Association recently partnered to increase Prostate cancer awareness. The partnership is also determined to increase the access points for cancer screening. Apart from working together for the fight against Prostate cancer, the organizations also work individually. The LabCorp, for instance, offered free Prostate Specific Antigen (PSA) screen to men with over 40 years. Only 2,000 men qualified for the free test. After the free test, LabCorp continued carrying out the screening at a discount of 25%. Many men benefited from the screening. Members of...

The Results of New Cancer Research

Cancer, Research
In a recent Surveillance, Epidemiology, and End Results program research conducted on 740, 990 persons, it was concluded that about 25 persons of older adults and 11 percent of younger adults diagnosed with cancer had a history of cancer. In other words, as the number of cancer survivors keeps growing, understanding the nature of prior cancer is important when it comes to improving the clinical trial accrual and patient experience. The goal of this study was to analyze the prevalence of prior cancer among persons who have previously been diagnosed with cancer as the population of cancer survivors keeps growing across the United States. The people who were analyzed in the research are individuals who have been diagnosed with cancer between January 2009 and December 2013. Prevalence of...